Myriad Genetics, Inc. (MYGN)
3.97
-0.25
(-5.92%)
USD |
NASDAQ |
May 29, 16:00
4.00
+0.03
(+0.76%)
After-Hours: 05:09
Myriad Genetics Total Liabilities (Quarterly) : 336.30M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Natera, Inc. | 840.38M |
| BioRestorative Therapies, Inc. | 1.615M |
| CareDx, Inc. | 97.53M |
| Exagen, Inc. | 37.52M |
| Sera Prognostics, Inc. | 25.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 673.70M |
| Shareholders Equity (Quarterly) | 337.40M |
| Debt to Equity Ratio | 0.6269 |
| Current Ratio | 2.402 |
| Net Debt Paydown Yield | -3.35% |